Lululemon Athletica gets one more downgrade ahead of Q3 report: 4 big analyst cuts
Investing.com | Author Davit Kirakosyan
Published Dec 05, 2023 08:16AM ET
Investing.com — Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at Lululemon Athletica, Albemarle , Toro, and STAAR Surgical.
Unlock the potential of InvestingPro.
This represents the second downgrade this week. Yesterday, Wells Fargo downgraded the company to Equal Weight from Overweight with a price target of $445.00, citing that valuation is no longer cheap and removing the stock from its Top Picks list.
The company is set to report its Q3/24 earnings on Dec 7, after the market close. Street estimates stand at $2.28 for EPS and $2.19 billion for revenues.
Albemarle drops on Piper Sandler downgrade/h2
Albemarle (NYSE:ALB) shares fell more than 2% pre-market today after Piper Sandler downgraded the company to Underweight from Neutral and cut its price target to $128.00 from $140.00.
Piper Sandler’s decision is influenced by the significant weakening in the global lithium market. The analysts believe the current market conditions are likely to prevent any notable recovery in lithium pricing for at least the next few quarters, which could lead to decreased earnings and lowered estimates.
Two more downgrades /h2
Toro (NASDAQ:TORO) shares fell more than 1% pre-market today after DA Davidson downgraded the company to Neutral from Buy with a price target of $87.00.
This decision is based on insights gathered from DA Davidson’s recent survey on golf course management and discussions with dealers and competitors in the industry. The analysts noted observations from Toro and Ditch Witch dealers during Q4, indicating expectations of a decrease in retail performance in 2024.
We also noted significant caution on FY:24 at a key TTC Professional competitor. Our golf course survey continues to show positive sentiment, in line with peer comments, but capex intentions may have inflected slightly.
Needham & Company downgraded STAAR Surgical (NASDAQ:STAA) to Hold from Buy. Shares fell more than 1% pre-market today.
Missed out on Black Friday? No problem, we've got you covered for
Get The News You Want
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.